András Vörös

637 total citations
34 papers, 343 citations indexed

About

András Vörös is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, András Vörös has authored 34 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 17 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in András Vörös's work include Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (14 papers) and HER2/EGFR in Cancer Research (6 papers). András Vörös is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (14 papers) and HER2/EGFR in Cancer Research (6 papers). András Vörös collaborates with scholars based in Hungary, United States and Finland. András Vörös's co-authors include Gábor Cserni, Katalin Ormándi, Tibor Nyári, Tibor Vályi-Nagy, Nóra Udvarhelyi, Klara Valyi‐Nagy, Tamás Zombori, Zsolt Simonka, György Lázár and Endre Kálmán and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

András Vörös

33 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
András Vörös Hungary 13 173 151 117 54 47 34 343
Lucia Mundo Italy 14 103 0.6× 235 1.6× 137 1.2× 172 3.2× 25 0.5× 24 438
Kai Hu China 13 106 0.6× 130 0.9× 74 0.6× 220 4.1× 28 0.6× 59 456
Guinebretière Jm France 11 209 1.2× 217 1.4× 128 1.1× 109 2.0× 47 1.0× 22 474
Katharina Balschun Germany 8 130 0.8× 260 1.7× 99 0.8× 175 3.2× 70 1.5× 8 619
David Arps United States 11 49 0.3× 100 0.7× 106 0.9× 47 0.9× 44 0.9× 22 302
Hillary Elwood United States 8 86 0.5× 195 1.3× 66 0.6× 94 1.7× 39 0.8× 26 367
Liza Ho Switzerland 10 96 0.6× 88 0.6× 57 0.5× 91 1.7× 31 0.7× 14 263
Geetha Menezes United States 8 66 0.4× 226 1.5× 132 1.1× 117 2.2× 40 0.9× 12 385
Bryan Gammon United States 10 62 0.4× 176 1.2× 54 0.5× 120 2.2× 7 0.1× 17 321
Scott R. Dalton United States 9 114 0.7× 363 2.4× 54 0.5× 203 3.8× 22 0.5× 23 561

Countries citing papers authored by András Vörös

Since Specialization
Citations

This map shows the geographic impact of András Vörös's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by András Vörös with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites András Vörös more than expected).

Fields of papers citing papers by András Vörös

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by András Vörös. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by András Vörös. The network helps show where András Vörös may publish in the future.

Co-authorship network of co-authors of András Vörös

This figure shows the co-authorship network connecting the top 25 collaborators of András Vörös. A scholar is included among the top collaborators of András Vörös based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with András Vörös. András Vörös is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuthi, Levente, et al.. (2023). TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(5). 861–868. 6 indexed citations
2.
Veréb, Zoltán, et al.. (2023). Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy. Pathology & Oncology Research. 28. 1610598–1610598. 2 indexed citations
3.
Tabár, Làszló, Peter B. Dean, F. Lee Tucker, et al.. (2023). Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypes. European Journal of Radiology. 166. 111021–111021.
4.
Cserni, Gábor, Balázs Járay, Endre Kálmán, et al.. (2022). Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer. Pathology & Oncology Research. 28. 1610373–1610373. 12 indexed citations
5.
Bori, Rita, István Sejben, András Vörös, et al.. (2021). The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(6). 1101–1109. 6 indexed citations
6.
7.
8.
Zombori, Tamás, et al.. (2020). A Clinicopathological Approach to Odontogenic Cysts: the Role of Cytokeratin 17 and bcl2 Immunohistochemistry in Identifying Odontogenic Keratocysts. Pathology & Oncology Research. 26(4). 2613–2620. 5 indexed citations
9.
Cserni, Gábor, Balázs Járay, Endre Kálmán, et al.. (2020). [Pathological diagnosis, work-up and reporting of breast cancer. Recommendations from the 4th Breast Cancer Consensus Conference].. PubMed. 64(4). 301–328. 5 indexed citations
10.
Vörös, András, et al.. (2018). Conjunctival melanocytic naevus: Diagnostic value of anterior segment optical coherence tomography and ultrasound biomicroscopy. PLoS ONE. 13(2). e0192908–e0192908. 22 indexed citations
11.
Rusz, Orsolya, András Vörös, Zoltán Varga, et al.. (2015). One-Year Neoadjuvant Endocrine Therapy in Breast Cancer. Pathology & Oncology Research. 21(4). 977–984. 13 indexed citations
12.
Vörös, András, Bence Kővári, Péter Lázár, et al.. (2014). Different Methods of Pretreatment Ki-67 Labeling Index Evaluation in Core Biopsies of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Their Relation to Response to Therapy. Pathology & Oncology Research. 21(1). 147–155. 18 indexed citations
13.
14.
Cserni, Gábor, Rita Bori, Róbert Maráz, et al.. (2012). Multi-Institutional Comparison of Non-sentinel Lymph Node Predictive Tools in Breast Cancer Patients with High Predicted Risk of Further Axillary Metastasis. Pathology & Oncology Research. 19(1). 95–101. 7 indexed citations
15.
Castellanos, Karla J., Klara Valyi‐Nagy, András Vörös, et al.. (2012). Increased axonal expression of nectin-1 in multiple sclerosis plaques. Neurological Sciences. 34(4). 465–469. 5 indexed citations
16.
Farkas, Viktor, Katalin Ormándi, András Vörös, et al.. (2012). The relationship of multifocality and tumor burden with various tumor characteristics and survival in early breast cancer. Neoplasma. 59(5). 566–573. 4 indexed citations
17.
Sükösd, Farkas, András Vörös, Katalin Ormándi, et al.. (2011). Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer. Oncology. 80(3-4). 269–277. 20 indexed citations
18.
Meriggioli, Matthew N., et al.. (2010). Hashimoto encephalopathy with fulminant myocarditis. Pathology - Research and Practice. 206(10). 720–722. 10 indexed citations
19.
20.
Valyi‐Nagy, Klara, Sándor Dósa, András Vörös, et al.. (2009). Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures. Cancer Gene Therapy. 17(4). 223–234. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Mundo Breakdown of academic impact, for papers by Kai Hu Breakdown of academic impact, for papers by Guinebretière Jm Breakdown of academic impact, for papers by Katharina Balschun Breakdown of academic impact, for papers by David Arps Breakdown of academic impact, for papers by Hillary Elwood Breakdown of academic impact, for papers by Liza Ho Breakdown of academic impact, for papers by Geetha Menezes Breakdown of academic impact, for papers by Bryan Gammon Breakdown of academic impact, for papers by Scott R. Dalton
Rankless by CCL
2026